Marie‐Thérèse Rubio

Predictive factors of early progression after CAR T-cell therapy in relapsed/refractory diffuse large B-cell lymphoma

Laëtitia Vercellino, Roberta Di Blasi, Salim Kanoun et al. · Blood Advances · 2020 · 404 citations · Full text

Medicine, Oncology, Cell Therapy +16

Impact of Azacitidine Before Allogeneic Stem-Cell Transplantation for Myelodysplastic Syndromes: A Study by the Société Française de Greffe de Moelle et de Thérapie-Cellulaire and the Groupe-Francophone des Myélodysplasies

Gandhi Damaj, Alain Duhamel, Marie Robin et al. · Journal of Clinical Oncology · 2012 · 206 citations · Full text

Medicine, Oncology, Pharmacology +15

Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of <i>FLT3</i>

Mark J. Levis, Mehdi Hamadani, Brent R. Logan et al. · Journal of Clinical Oncology · 2024 · 185 citations · Full text

Medicine, Hematology, Pharmacotherapy +11

Diagnostic contribution of positron emission tomography with [18F]fluorodeoxyglucose for invasive fungal infections

A. Hot, C. Maunoury, S. Poirée et al. · Clinical Microbiology and Infection · 2010 · 160 citations · Full text

Medicine, Infectious Diseases, Radiology +15

CD4 ⁺ CD25 ⁺ Regulatory T Cell Depletion Improves the Graft-Versus-Tumor Effect of Donor Lymphocytes After Allogeneic Hematopoietic Stem Cell Transplantation

Sébastien Maury, François M. Lemoine, Yosr Hicheri et al. · Science Translational Medicine · 2010 · 142 citations

Life Sciences, Hematology, Immunology +14